tirzepatide dose equivalent to semaglutide vs. for Weight Loss Switching from Semaglutide to Tirzepatide:

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, a novel class of medication that targets both GIP and GLP-1 receptors to enhance insulin secretion, suppress glucagon release, and slow gastric emptying

For women with PCOS who are overweight or obese (BMI 30, or 27 with additional metabolic risk factors) and face challenges like insulin resistance or metabolic syndrome, tirzepatide offers a well-rounded treatment option

With rising costs and new supply challenges, many are rethinking their options

If trial endpoints meet expectations, FDA approval could come in coming years

However, our spinal doctor will carefully monitor your response to the injections to ensure that you do not experience any unwanted side effects